ARCHIVES

Phase IIb Trial of CRLX101 Fails Overall Survival Endpoint

This article is from The Cancer Letter archive.

Vol. 36 No. 3 | March 29, 2013

Download PDF Visit The Full Archive

Related Articles

NCAB Member Becker Says AACR ‘Feels Disenfranchised’

December 6, 1991

NCI Plans Briefing Oct. 8 In St. Louis for SPORE Applicants

August 23, 1991

Alimta/Cisplatin Chemotherapy Increased Overall Survival

June 29, 2012

NCI Implementing Changes In Organ Site Program, Directing Grant applications To NIH Study Sections

October 15, 1982

Bisphosphonates May Reduce Recurrent Breast Cancer

December 25, 2009

PhRMA Offers Assistance For Part D “Doughnut Hole”

June 26, 2009